185 related articles for article (PubMed ID: 2465818)
1. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate.
Ogunlewe JO; Osegbe DN
Cancer; 1989 Apr; 63(7):1388-92. PubMed ID: 2465818
[TBL] [Abstract][Full Text] [Related]
2. Androgen concentration in blacks with benign and malignant prostatic disease.
Osegbe DN; Ogunlewe JO
J Urol; 1988 Jul; 140(1):160-4. PubMed ID: 2454327
[TBL] [Abstract][Full Text] [Related]
3. Zinc and cadmium concentrations in whole tissue and in separated epithelium and stroma from human benign prostatic hypertrophic glands.
Lahtonen R
Prostate; 1985; 6(2):177-83. PubMed ID: 2579370
[TBL] [Abstract][Full Text] [Related]
4. Metal-androgen interrelationships in carcinoma and hyperplasia of the human prostate.
Habib FK; Hammond GL; Lee IR; Dawson JB; Mason MK; Smith PH; Stitch SR
J Endocrinol; 1976 Oct; 71(1):133-41. PubMed ID: 62007
[TBL] [Abstract][Full Text] [Related]
5. Zinc and cadmium in cell fractions of prostatic cancer tissues of different histological grading in comparison to BPH and normal prostate.
Feustel A; Wennrich R
Urol Res; 1984; 12(2):147-50. PubMed ID: 6204433
[TBL] [Abstract][Full Text] [Related]
6. Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH).
Feustel A; Wennrich R; Steiniger D; Klauss P
Urol Res; 1982; 10(6):301-3. PubMed ID: 6186062
[TBL] [Abstract][Full Text] [Related]
7. Zinc and cadmium analysis in human prostate neoplasms.
Bryś M; Nawrocka AD; Miekoś E; Zydek C; Foksiński M; Barecki A; Krajewska WM
Biol Trace Elem Res; 1997; 59(1-3):145-52. PubMed ID: 9522056
[TBL] [Abstract][Full Text] [Related]
8. Determination of the distribution of zinc and cadmium in cellular fractions of BPH, normal prostate and prostatic cancers of different histologies by atomic and laser absorption spectrometry in tissue slices.
Feustel A; Wennrich R
Urol Res; 1984; 12(5):253-6. PubMed ID: 6083653
[TBL] [Abstract][Full Text] [Related]
9. Cadmium exposure and the risk of prostate cancer among Nigerian men: Effect modification by zinc status.
Bede-Ojimadu O; Nnamah N; Onuegbu J; Grant-Weaver I; Barraza F; Orakwe J; Abiahu J; Orisakwe OE; Nriagu J
J Trace Elem Med Biol; 2023 Jul; 78():127168. PubMed ID: 37043921
[TBL] [Abstract][Full Text] [Related]
10. [Zinc levels in prostatic fluid of patients with prostate pathologies].
Gómez Y; Arocha F; Espinoza F; Fernández D; Vásquez A; Granadillo V
Invest Clin; 2007 Sep; 48(3):287-94. PubMed ID: 17853788
[TBL] [Abstract][Full Text] [Related]
11. Cadmium concentration and metallothionein expression in prostate cancer and benign prostatic hyperplasia of humans.
Lee JD; Wu SM; Lu LY; Yang YT; Jeng SY
J Formos Med Assoc; 2009 Jul; 108(7):554-9. PubMed ID: 19586829
[TBL] [Abstract][Full Text] [Related]
12. Biochemical profiles of prostatic fluid from normal and diseased prostate glands.
Grayhack JT; Lee C; Oliver L; Schaeffer AJ; Wendel EF
Prostate; 1980; 1(2):227-37. PubMed ID: 15619922
[TBL] [Abstract][Full Text] [Related]
13. Zinc, cadmium and selenium concentrations in separated epithelium and stroma from prostatic tissues of different histology.
Feustel A; Wennrich R; Dittrich H
Urol Res; 1987; 15(3):161-3. PubMed ID: 3629750
[TBL] [Abstract][Full Text] [Related]
14. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.
Muecke R; Klotz T; Giedl J; Buentzel J; Kundt G; Kisters K; Prott FJ; Micke O
Acta Oncol; 2009; 48(3):452-6. PubMed ID: 18855158
[TBL] [Abstract][Full Text] [Related]
15. Zinc in the human prostate gland: normal, hyperplastic and cancerous.
Zaichick VYe ; Sviridova TV; Zaichick SV
Int Urol Nephrol; 1997; 29(5):565-74. PubMed ID: 9413764
[TBL] [Abstract][Full Text] [Related]
16. Zinc and cadmium plasma and erythrocyte levels in prostatic carcinoma, BPH, urological malignancies, and inflammations.
Feustel A; Wennrich R
Prostate; 1986; 8(1):75-9. PubMed ID: 2418432
[TBL] [Abstract][Full Text] [Related]
17. Oxidative damage in patients with benign prostatic hyperplasia and prostate cancer co-exposed to phthalates and to trace elements.
Chang WH; Lee CC; Yen YH; Chen HL
Environ Int; 2018 Dec; 121(Pt 2):1179-1184. PubMed ID: 30808488
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of trace elements in hair of patients with prostate carcinoma, benign prostatic hypertrophy, and normal controls].
Ouyang SY; Li SL
Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):279-80. PubMed ID: 12212167
[TBL] [Abstract][Full Text] [Related]
19. Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma.
Christudoss P; Selvakumar R; Fleming JJ; Gopalakrishnan G
Indian J Urol; 2011 Jan; 27(1):14-8. PubMed ID: 21716879
[TBL] [Abstract][Full Text] [Related]
20. Association of Pb, Cd, and Se concentrations and oxidative damage-related markers in different grades of prostate carcinoma.
Guzel S; Kiziler L; Aydemir B; Alici B; Ataus S; Aksu A; Durak H
Biol Trace Elem Res; 2012 Jan; 145(1):23-32. PubMed ID: 21809052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
